PMID: 2497754Apr 1, 1989Paper

Evaluation of a disk approximation test of inducible beta-lactamases in Enterobacteriacae and Pseudomonas aeruginosa

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
M ThoreK Dornbusch

Abstract

A modified disk approximation test of inducible beta-lactamases in Enterobacteriacae and Pseudomonas aeruginosa was evaluated. The amount of inducer was adapted to produce the smallest possible zone of inhibition and the distance between the centre of the disks was standardized. Among several beta-lactam antibiotic disks tested, imipenem (0.06 microgram per disk) or cefoxitin (10 micrograms per disk) placed at a distance of 14-16 mm from a cefotaxime disk (30 micrograms) most efficiently revealed inducible beta-lactamases. A positive induction test (primarily expected with Enterobacter spp, Citrobacter freundii, Serratia spp, Pseudomonas aeruginosa and indole positive Proteus spp) may serve as a warning of the risk of selecting mutants with beta-lactamase mediated cross-resistance during systemic treatment with ureidopenicillins, later generations of cephalosporins or monobactams. Such resistance was exemplified by characterization of some laboratory mutants with hyperproduction of beta-lactamases. However, evaluation of the specificity and sensitivity of the disk approximation test (and other indirect induction tests) still remains to be done.

References

Jun 1, 1979·Antimicrobial Agents and Chemotherapy·C C Sanders, W E Sanders
Sep 21, 1985·Lancet·M J Weinbren, R M Perinpanayagam
Aug 1, 1986·The Journal of Infectious Diseases·J P QuinnS A Lerner
Sep 1, 1986·Antimicrobial Agents and Chemotherapy·M L GatesW E Sanders
Oct 1, 1986·Antimicrobial Agents and Chemotherapy·F Tausk, C W Stratton
May 1, 1986·Journal of Medical Microbiology·V A Moritz, P B Carson
Aug 1, 1987·European Journal of Clinical Microbiology·D L DworzackE A Horowitz
Sep 1, 1986·Antimicrobial Agents and Chemotherapy·R Wise
Apr 1, 1985·Antimicrobial Agents and Chemotherapy·R E Menzies, D MacCulloch
Jun 1, 1985·The Journal of Antimicrobial Chemotherapy·K DornbuschG H Miller
Jul 1, 1985·Antimicrobial Agents and Chemotherapy·F TauskC W Stratton
Jan 1, 1973·Antimicrobial Agents and Chemotherapy·F A Rubin, D H Smith
Jun 1, 1984·Journal of Medical Microbiology·R J WilliamsJ D Williams
Jun 1, 1982·Antimicrobial Agents and Chemotherapy·C C SandersR V Goering
Sep 1, 1980·The Journal of Antimicrobial Chemotherapy·K Shannon, I Phillips

❮ Previous
Next ❯

Citations

May 1, 1990·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·E LindhA Forsgren

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.